Sabina Baskhanova

Ms. Sabina Baskhanova

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2022 in Metabolites
Verified
Journal Article
Open access
PDF file
NMNatalia Moskaleva
Natalia Moskaleva
KSKsenia Shestakova
Ksenia Shestakova
AKAlexey V. Kukharenko
Alexey V. Kukharenko
PMPavel Markin
Pavel Markin
MKMaria Kozhevnikova
Maria Kozhevnikova
SASvetlana Appolonova
Svetlana Appolonova
Metabolomics is a promising technology for the application of translational medicine to cardiovascular risk. Here, we applied a liquid chromatography/tandem mass spectrometry approach to explore the associations between plasma concentrations of amino acids, methylarginines, acylcarnitines, and tryptophan catabolism metabolites and cardiometabolic risk factors in patients diagnosed with arterial hypertension (HTA) (n = 61), coronary artery disease (CAD) (n = 48), and non-cardiovascular disease (CVD) individuals (n = 27). In total, almost all significantly different acylcarnitines, amino acids, methylarginines, and intermediates of the kynurenic and indolic tryptophan conversion pathways presented increased (p < 0.05) in concentration levels during the progression of CVD, indicating an association of inflammation, mitochondrial imbalance, and oxidative stress with early stages of CVD. Additionally, the random forest algorithm was found to have the highest prediction power in multiclass and binary classification patients with CAD, HTA, and non-CVD individuals and globally between CVD and non-CVD individuals (accuracy equal to 0.80 and 0.91, respectively). Thus, the present study provided a complex approach for the risk stratification of patients with CAD, patients with HTA, and non-CVD individuals using targeted metabolomics profiling.

15 July 2025 in Journal of Chromatography B
Verified
Journal Article
Closed access
SBSabina Baskhanova
Sabina Baskhanova
NMNatalia E. Moskaleva
Natalia E. Moskaleva
KSKsenia M. Shestakova
Ksenia M. Shestakova
MKMaria V. Kozhevnikova
Maria V. Kozhevnikova
EKEkaterina O. Korobkova
Ekaterina O. Korobkova
SASvetlana A. Appolonova
Svetlana A. Appolonova

7 July 2025 in Kardiologiia
Verified
Journal Article
Closed access
YKYu. Yu. Kirichenko
Yu. Yu. Kirichenko
VVV. G. Varsieva
V. G. Varsieva
KSKsenia Shestakova
Ksenia Shestakova
ACA. D. Chernichkina
A. D. Chernichkina
APA. V. Palienko
A. V. Palienko
SASvetlana Appolonova
Svetlana Appolonova
Aim To determine the array of metabolomic profiles and structural and functional parameters of the vascular wall associated with the risk of cardiovascular toxicity of antitumor therapy (ATT) in oncohematological patients. Material and methods This study included 59 patients, among them 34 patients with lymphomas (non-Hodgkin and Hodgkin lymphoma) and 25 with multiple myeloma. Before and after 3 courses of ATT (anthracyclines, proteasome inhibitors), finger photoplethysmography and transthoracic echocardiography were performed as well as metabolomic profiling (98 metabolites) by high-performance liquid chromatography in combination with tandem mass spectrometry. Statistical analysis of the results included parametric and nonparametric tests, logistic regression, and cross-validation. Results The study showed that even before the initiation of ATT, cancer patients had signs of endothelial dysfunction and increased vascular wall stiffness (increased aSI, RI, and IO indices), which significantly worsened after the specific treatment. Metabolomic profiling identified a set of metabolites associated with the risk of cardiovascular toxicity, including increased concentrations of amino acids (asparagine, serine, glutamate, glutamine, taurine, citrulline), short-chain acylcarnitines (C18:1 OH-carnitine, C16:1 OH-carnitine, C14OH-carnitine, C2 carnitine), choline metabolism intermediates (TMAO, dimethylglycine, choline), tryptophan metabolites (hydroxyindoleacetic acid, kynurenic acid). Additionally, a logistic regression model was developed based on the analysis of the metabolomic profile, which showed a high prognostic power (AUC = 0.84) for predicting cardiovascular toxicity of ATT. Conclusion The study identified key metabolites and structural and functional parameters of blood vessels that allow detection of an increased risk of cardiovascular complications of ATT in patients with lymphomas and multiple myeloma before the initiation of a specific treatment. Increased concentrations of amino acids, acylcarnitines, and choline metabolites may serve as an additional risk factor for the onset/progression of cardiovascular complications. The proposed integrative approach, including both metabolomic profiling and non-invasive assessment of the vascular wall condition, opens broad prospects for personalized cardioprotection of cancer patients and more accurate monitoring of the cardiovascular status during ATT.

1 February 2024 in Pharmaceutical Chemistry Journal
Verified
Journal Article
Closed access
PDF file
SBSabina Baskhanova
Sabina Baskhanova
MSM. V. Savitskii
M. V. Savitskii
NMN. E. Moskaleva
N. E. Moskaleva
VSV. M. Samoylov
V. M. Samoylov
NLN. L. Lubenec
N. L. Lubenec
SAS. A. Appolonova
S. A. Appolonova

23 July 2025 in Pharmacy & Pharmacology
Verified
Journal Article
Open access
PDF file
NMNatalia Moskaleva
Natalia Moskaleva
PRP. M. Rezvanov
P. M. Rezvanov
VSV. M. Samoylov
V. M. Samoylov
VVValeria Varzieva
Valeria Varzieva
SBSabina Baskhanova
Sabina Baskhanova
SASvetlana Appolonova
Svetlana Appolonova
The aim. To investigate the metabolic profile of zebrafish embryos when exposed to drugs with known risks of cardiotoxicity, such as acetaminophen, carbamazepine, salbutamol, ketorolac, bisoprolol, and metoprolol. The analysis is aimed at detecting changes in the level of amino acids (including branched chain BCAAs), products of carnitine metabolism (acylcarnitines) and related metabolic indices reflecting mitochondrial dysfunction, oxidative stress and disorders of the nitric oxide signaling pathway. Materials and methods. Zebrafish embryos were incubated with the test substances in a concentration gradient (0.5–10×NOEC). A quantitative targeted metabolomics analysis was performed using high-performance liquid chromatography with tandem mass spectrometry (HPLC–MS/MS) with a panel of 98 metabolites (amino acids, nitric oxide metabolism products, vitamins, nucleosides and acylcarnitines). The obtained concentrations of metabolites were compared with the control (0.1% DMSO). Statistically significant deviations were expressed as the ratio of concentration to control on a base 2 logarithmic scale (log2FC).Results. Changes in concentrations of metabolites under the influence of cardiotoxic drugs were revealed. There was an accumulation of BCAAs (the sum of leucine, isoleucine, valine; log2FC≈0.5–2.2; p <0.05) compared with the control, as well as an increase in the level of acylcarnitines, indicating mitochondrial dysfunction: for example, metoprolol and bisoprolol caused an increase in the ratio of the sum of acylcarnitines to free carnitine by more than 4–6 times (log2FC=+3.8 for bisoprolol and -1.27 for metoprolol; p <0.01), as well as accumulation of long-chain acylcarnitines. Pronounced changes in indicators related to oxidative stress were noted: in the samples after exposure to beta-1 blockers (bisoprolol, metoprolol) and ketorolac, the concentration of methionine sulfoxide (by 80–130%, p < 0.01), the product of methionine oxidation, and the ratio of methionine sulfoxide/methionine increased, whereas when exposed to salbutamol, on the contrary, the level of methionine sulfoxide decreased (-120%, p <0.01), indicating a multidirectional effect on the oxidative status. Violations of the nitric oxide signaling pathway were reflected in an increase in the level of asymmetric dimethylarginine. Conclusion. Each of the analyzed compounds produced a specific metabolic “imprint” in Zebrafish samples, reflecting the mechanisms of their cardiotoxicity. An increase in BCAA levels and related indicators indicates a violation of myocardial energy metabolism, the accumulation of long-chain acylcarnitines indicates incomplete beta-oxidation of fatty acids. An increase in the concentration of ADMA is associated with endothelial dysfunction, and an increase in methionine sulfoxide is associated with increased oxidative stress.

30 July 2023 in "Medical & Pharmaceutical Journal "Pulse"
Verified
Journal Article
Closed access
SVSamoilov V.M.
Samoilov V.M.
SMSavitskii M.V.
Savitskii M.V.
SBSabina Baskhanova
Sabina Baskhanova
SASvetlana Appolonova
Svetlana Appolonova
RARomashkina A.G.
Romashkina A.G.